These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18603330)

  • 1. Explorations into modeling human oral bioavailability.
    Wang Z; Yan A; Yuan Q; Gasteiger J
    Eur J Med Chem; 2008 Nov; 43(11):2442-52. PubMed ID: 18603330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of Gibbs energy of formation of organic compounds by linear and nonlinear methods.
    Yan A
    J Chem Inf Model; 2006; 46(6):2299-304. PubMed ID: 17125172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.
    Tian S; Li Y; Wang J; Zhang J; Hou T
    Mol Pharm; 2011 Jun; 8(3):841-51. PubMed ID: 21548635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
    Wang J; Krudy G; Xie XQ; Wu C; Holland G
    J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative multiple quantitative structure-retention relationships modeling of gas chromatographic retention time of essential oils using multiple linear regression, principal component regression, and partial least squares techniques.
    Qin LT; Liu SS; Liu HL; Tong J
    J Chromatogr A; 2009 Jul; 1216(27):5302-12. PubMed ID: 19486989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability and first-pass effects.
    Kwan KC
    Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using classification structure pharmacokinetic relationship (SCPR) method to predict drug bioavailability based on grid-search support vector machine.
    Wang J; Du H; Yao X; Hu Z
    Anal Chim Acta; 2007 Oct; 601(2):156-63. PubMed ID: 17920387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of molecular properties on oral bioavailability of lipophilic drugs - mapping of bulkiness and different measures of polarity.
    Kuentz MT; Arnold Y
    Pharm Dev Technol; 2009; 14(3):312-20. PubMed ID: 19235630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modeling of human oral bioavailability: what will be next?
    Cabrera-Pérez MÁ; Pham-The H
    Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
    Massarelli I; Macchia M; Minutolo F; Prota G; Bianucci AM
    Bioorg Med Chem; 2009 May; 17(10):3543-56. PubMed ID: 19398207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of classification regression tree in predicting oral absorption in humans.
    Bai JP; Utis A; Crippen G; He HD; Fischer V; Tullman R; Yin HQ; Hsu CP; Jiang L; Hwang KK
    J Chem Inf Comput Sci; 2004; 44(6):2061-9. PubMed ID: 15554676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of rhabdomyolysis of compounds by self-organizing map and support vector machine.
    Hu X; Yan A
    Toxicol In Vitro; 2011 Dec; 25(8):2017-24. PubMed ID: 21856410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico log P prediction for a large data set with support vector machines, radial basis neural networks and multiple linear regression.
    Chen HF
    Chem Biol Drug Des; 2009 Aug; 74(2):142-7. PubMed ID: 19549084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the performances of quantitative structure-retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions.
    Wang C; Skibic MJ; Higgs RE; Watson IA; Bui H; Wang J; Cintron JM
    J Chromatogr A; 2009 Jun; 1216(25):5030-8. PubMed ID: 19439313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advance in predicting oral bioavailability].
    Ma GL; Cheng YY
    Yao Xue Xue Bao; 2006 Oct; 41(10):917-20. PubMed ID: 17184106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.